Related references
Note: Only part of the references are listed.Outcome After PSMA PET/CT-Based Salvage Radiotherapy in Patients with Biochemical Recurrence After Radical Prostatectomy: A 2-Institution Retrospective Analysis
Nina-Sophie Schmidt-Hegemann et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Oligometastatic prostate cancer and salvage lymph node dissection: systematic review
Aldo Brassetti et al.
MINERVA CHIRURGICA (2019)
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva et al.
EUROPEAN UROLOGY (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
Nat P. Lenzo et al.
DIAGNOSTICS (2018)
The Role of Local Therapy for Oligometastatic Prostate Cancer Should We Expect a Cure?
Rajesh Nair et al.
UROLOGIC CLINICS OF NORTH AMERICA (2017)
Targeting MicroRNAs in Prostate Cancer Radiotherapy
Jie Ni et al.
THERANOSTICS (2017)
Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence
Jason Bailey et al.
CURRENT UROLOGY REPORTS (2017)
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy
Elnaz Pashaei et al.
PLOS ONE (2017)
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes
Barbara Alicja Jereczek-Fossa et al.
CLINICAL GENITOURINARY CANCER (2017)
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Noura Radwan et al.
BMC CANCER (2017)
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
Laura Evangelista et al.
EUROPEAN UROLOGY (2016)
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
Helle Kristensen et al.
Oncotarget (2016)
OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer
Stephane Supiot et al.
BMC CANCER (2015)
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
Piet Ost et al.
EUROPEAN UROLOGY (2015)
A Novel MiRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy
Erica Hlavin Bell et al.
PLOS ONE (2015)
Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only
Hans Christian Rischke et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2015)
Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil
Kazuhiro Kitajima et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?
Ivan R. Vogelius et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
HIGH OCCURRENCE OF ABERRANT LYMPH NODE SPREAD ON MAGNETIC RESONANCE LYMPHOGRAPHY IN PROSTATE CANCER PATIENTS WITH A BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
Hanneke J. M. Meijer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
ROBOTIC IMAGE-GUIDED STEREOTACTIC RADIOTHERAPY, FOR ISOLATED RECURRENT PRIMARY, LYMPH NODE OR METASTATIC PROSTATE CANCER
Barbara Alicja Jereczek-Fossa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy
Raymond Miralbell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?
CL Amling et al.
JOURNAL OF UROLOGY (2001)
Share Paper
